These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7734470)

  • 1. Imipramine for the treatment of cocaine and methamphetamine dependence.
    Galloway GP; Newmeyer J; Knapp T; Stalcup SA; Smith D
    J Addict Dis; 1994; 13(4):201-16. PubMed ID: 7734470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A controlled trial of imipramine for the treatment of methamphetamine dependence.
    Galloway GP; Newmeyer J; Knapp T; Stalcup SA; Smith D
    J Subst Abuse Treat; 1996; 13(6):493-7. PubMed ID: 9219147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imipramine treatment of cocaine abuse: possible boundaries of efficacy.
    Nunes EV; McGrath PJ; Quitkin FM; Ocepek-Welikson K; Stewart JW; Koenig T; Wager S; Klein DF
    Drug Alcohol Depend; 1995 Oct; 39(3):185-95. PubMed ID: 8556967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of lisuride on mood and sleep during acute withdrawal in stimulant abusers: a preliminary report.
    Gillin JC; Pulvirenti L; Withers N; Golshan S; Koob G
    Biol Psychiatry; 1994 Jun; 35(11):843-9. PubMed ID: 8054406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pexacerfont as a CRF1 antagonist for the treatment of withdrawal symptoms in men with heroin/methamphetamine dependence: a randomized, double-blind, placebo-controlled clinical trial.
    Morabbi MJ; Razaghi E; Moazen-Zadeh E; Safi-Aghdam H; Zarrindast MR; Vousoghi N; Akhondzadeh S
    Int Clin Psychopharmacol; 2018 Mar; 33(2):111-119. PubMed ID: 29064909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Matrix model of outpatient stimulant abuse treatment: evidence of efficacy.
    Shoptaw S; Rawson RA; McCann MJ; Obert JL
    J Addict Dis; 1994; 13(4):129-41. PubMed ID: 7734464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence.
    Longo M; Wickes W; Smout M; Harrison S; Cahill S; White JM
    Addiction; 2010 Jan; 105(1):146-54. PubMed ID: 19839966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of oral methamphetamine on cocaine use: a randomized, double-blind, placebo-controlled trial.
    Mooney ME; Herin DV; Schmitz JM; Moukaddam N; Green CE; Grabowski J
    Drug Alcohol Depend; 2009 Apr; 101(1-2):34-41. PubMed ID: 19058926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized double-blind study of neuroelectric therapy in opiate and cocaine detoxification.
    Gariti P; Auriacombe M; Incmikoski R; McLellan AT; Patterson L; Dhopesh V; Mezochow J; Patterson M; O'Brien C
    J Subst Abuse; 1992; 4(3):299-308. PubMed ID: 1458046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LiMA: a study protocol for a randomised, double-blind, placebo controlled trial of lisdexamfetamine for the treatment of methamphetamine dependence.
    Ezard N; Dunlop A; Hall M; Ali R; McKetin R; Bruno R; Phung N; Carr A; White J; Clifford B; Liu Z; Shanahan M; Dolan K; Baker AL; Lintzeris N
    BMJ Open; 2018 Jul; 8(7):e020723. PubMed ID: 30030312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imipramine treatment of opiate-dependent patients with depressive disorders. A placebo-controlled trial.
    Nunes EV; Quitkin FM; Donovan SJ; Deliyannides D; Ocepek-Welikson K; Koenig T; Brady R; McGrath PJ; Woody G
    Arch Gen Psychiatry; 1998 Feb; 55(2):153-60. PubMed ID: 9477929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms.
    Kampman KM; Dackis C; Lynch KG; Pettinati H; Tirado C; Gariti P; Sparkman T; Atzram M; O'Brien CP
    Drug Alcohol Depend; 2006 Nov; 85(2):129-37. PubMed ID: 16697124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Stimulant Selective Severity Assessment: A replication and exploratory extension of the Cocaine Selective Severity Assessment.
    Walker R; Northrup TF; Tillitski J; Bernstein I; Greer TL; Trivedi MH
    Subst Use Misuse; 2019; 54(3):351-361. PubMed ID: 30657406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotics for cocaine or psychostimulant dependence: systematic review and meta-analysis of randomized, placebo-controlled trials.
    Kishi T; Matsuda Y; Iwata N; Correll CU
    J Clin Psychiatry; 2013 Dec; 74(12):e1169-80. PubMed ID: 24434105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing the effect of buprenorphine and methadone in the reduction of methamphetamine craving: a randomized clinical trial.
    Ahmadi J; Razeghian Jahromi L
    Trials; 2017 Jun; 18(1):259. PubMed ID: 28587620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of amantadine and desipramine combined with psychotherapy for treatment of cocaine dependence.
    Weddington WW; Brown BS; Haertzen CA; Hess JM; Mahaffey JR; Kolar AF; Jaffe JH
    Am J Drug Alcohol Abuse; 1991 Jun; 17(2):137-52. PubMed ID: 1862788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, double-blind, placebo-controlled trial of vigabatrin for the treatment of cocaine dependence in Mexican parolees.
    Brodie JD; Case BG; Figueroa E; Dewey SL; Robinson JA; Wanderling JA; Laska EM
    Am J Psychiatry; 2009 Nov; 166(11):1269-77. PubMed ID: 19651710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, controlled, pilot trial of methylphenidate and cognitive-behavioral group therapy for cocaine dependence in heroin prescription.
    Dürsteler-MacFarland KM; Farronato NS; Strasser J; Boss J; Kuntze MF; Petitjean SA; Bürki C; Wiesbeck GA
    J Clin Psychopharmacol; 2013 Feb; 33(1):104-8. PubMed ID: 23277248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of desipramine or carbamazepine on patient retention in outpatient cocaine treatment: preliminary findings.
    Campbell JL; Thomas HM; Gabrielli W; Liskow BI; Powell BJ
    J Addict Dis; 1994; 13(4):191-9. PubMed ID: 7734469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study.
    Petry NM; Peirce JM; Stitzer ML; Blaine J; Roll JM; Cohen A; Obert J; Killeen T; Saladin ME; Cowell M; Kirby KC; Sterling R; Royer-Malvestuto C; Hamilton J; Booth RE; Macdonald M; Liebert M; Rader L; Burns R; DiMaria J; Copersino M; Stabile PQ; Kolodner K; Li R
    Arch Gen Psychiatry; 2005 Oct; 62(10):1148-56. PubMed ID: 16203960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.